354 related articles for article (PubMed ID: 19606159)
1. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
[TBL] [Abstract][Full Text] [Related]
2. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
3. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
5. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
6. Management of iris melanomas with 125Iodine plaque radiotherapy.
Fernandes BF; Krema H; Fulda E; Pavlin CJ; Payne DG; McGowan HD; Simpson ER
Am J Ophthalmol; 2010 Jan; 149(1):70-6. PubMed ID: 19892312
[TBL] [Abstract][Full Text] [Related]
7. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
8. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
10. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
Bornfeld N; Chauvel P; Sauerwein W; Friedrichs W; Tiburtius T; Wessing A; Foerster MH
Front Radiat Ther Oncol; 1997; 30():97-110. PubMed ID: 9205890
[No Abstract] [Full Text] [Related]
11. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
van Ginderdeuren R; van Limbergen E; Spileers W
Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body.
Liszauer AD; Brownstein S; Corriveau C; Deschênes J
Can J Ophthalmol; 1990 Dec; 25(7):340-4. PubMed ID: 2090338
[TBL] [Abstract][Full Text] [Related]
13. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
Torres VL; Allemann N; Erwenne CM
Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of cataract surgery in eyes with ocular melanoma treated with iodine-125 brachytherapy.
Bozkurt TK; Tang Q; Grunstein LL; McCannel TA; Straatsma BR; Miller KM
J Cataract Refract Surg; 2018 Mar; 44(3):287-294. PubMed ID: 29703285
[TBL] [Abstract][Full Text] [Related]
16. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
17. Palladium-103 plaque radiation therapy for ciliary body melanoma through a functioning glaucoma filtering bleb.
Pathan AHK; Barash A; Tena LB; Finger PT
Eur J Ophthalmol; 2018 Jan; 28(1):119-122. PubMed ID: 28967074
[TBL] [Abstract][Full Text] [Related]
18. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
Pe'er J; Averbukh E; Frenkel S
Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
[No Abstract] [Full Text] [Related]
19. [Surgical management of ciliary body melanoma].
Romanowska-Dixon B
Klin Oczna; 2005; 107(10-12):627-31. PubMed ID: 16619806
[TBL] [Abstract][Full Text] [Related]
20. 125I plaque brachytherapy for anterior uveal melanomas.
Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
